From COVID-19 to climate change to vulvovaginal candidiasis, the annual meeting offered something for everyone.
For the first time in 3 years, experts from the United States and beyond reunited in person for the American College of Obstetricians and Gynecologists’ Annual Clinical & Scientific Meeting held in May in San Diego, California. Clinicians received updates on the latest research, newest technologies, and best clinical recommendations in obstetrics and gynecology.
This year’s theme was “Reconnect, recharge, and reset,” and every facet of the meeting reflected that. Attendees engaged in meaningful discussions, rediscovered their passions, and identified the pulse of the industry—from adapting to the climate crisis and changes in abortion care legislation to embracing artificial intelligence in their daily practice.
Contemporary OB/GYN®’s editorial team was onsite covering an array of topics such as social media misinformation, digital apps in obstetric care, contraception, and osteoporosis management guidelines.
Some sessions of note include:
Asthma. Allergies. Eczema. Type 2 diabetes. Nathaniel DeNicola, MD, MSHP; Emily Sbiroli, MD; Vi Nguyen, MD, FAAP; and Colin Nackerman, MD, spoke about disease states caused or exacerbated by climate change, and what clinicians can do to mitigate
this crisis.
There have been many unknowns surrounding COVID-19 vaccination and adverse effects, but to women in their childbearing years, the possible impact on their fertility and fetal health may carry the most weight. Three experts sought to outline exactly how vaccination against COVID-19 could affect reproductive health, fertility, and infant outcomes.
Lyndsey Harper, MD, FACOG, IF; and Laurie Mintz, PhD, explained how obstetrician-gynecologists can help women take charge of their sexual function and how to address internalized shame, medical contributors to sexual dysfunction, and treatment plans for your patients.
Metrics, wellness models, and management change are essential to advancing diversity, equity, and inclusion in obstetrics and gynecology, according to an EdTalk presented by Lisa Foglia, MD, FACOG; Andrea L. Braden, MD, FACOG; and Catherine Cansino, MD, MPH.
Jack Sobel, MD, discussed how recurrent vulvovaginal candidiasis (RVVC), a chronic version of vulvovaginal candidiasis, affects women. He also delved into past treatments and the newly FDA-approved drug oteseconazole (Vivjoa; Mycovia).
Multiple posters and abstracts also displayed study data on a variety of topics including postpartum depression and intrauterine device use, as well as experiences with use of medication abortion before and during the COVID-19 pandemic.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More